Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)

Pulse Biosciences' quarterly Finished Goods came in at $750000.0 in Q3 2022, down 55.91% year-on-year from $1.7 million in Q3 2021, and down 71.0% quarter-over-quarter from $2.6 million in Q2 2022.

Pulse Biosciences has reported Finished Goods for 2 years, with the latest figure at $750000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Finished Goods fell 55.91% year-over-year to $750000.0; the trailing twelve-month figure through Sep 2022 stood at $750000.0 (down 55.91% YoY), and the FY2021 full-year result was $2.4 million, changed N/A from the prior year.
  • Finished Goods for Q3 2022 stood at $750000.0, down from $2.6 million in the prior quarter.
  • The five-year high for Finished Goods was $2.7 million in Q1 2022, with the low at $750000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pulse Biosciences 1.72 Bn 1.72 Bn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 750,000.00
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.74 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 1.70 Mn